- StudyBlue
- Connecticut
- University of Connecticut
- Pharmacy
- Pharmacy 3040
- Jeffery
- Opiates/Narcotic Analgesics (class hour 36 3/17/11)
Opiates/Narcotic Analgesics (class hour 36 3/17/11)
Pharmacy 3040 with Jeffery at University of Connecticut
About this deck
By: Joshua Pruitt
Textbook:
Pharmacotherapy Handbook, Seventh Edition
Created: 2011-03-28
Size: 26 flashcards
Views: 16
Textbook:
Pharmacotherapy Handbook, Seventh EditionCreated: 2011-03-28
Size: 26 flashcards
Views: 16
About StudyBlue
STUDYBLUE makes things that make you better at school.
Things like online flashcards with photos and audio.
Things like personalized quizzes and friendly reminders about when (and what) to study next.
Think of it as a digital backpack™: access to all of your study materials online and on your phone.
STUDYBLUE exists to make studying efficient and effective for every student, for free. Join us.
“I have been getting MUCH better grades on all my tests for school. Flash cards, notes, and quizzes are great on here. Thanks!”
Kathy
Kathy
Sign up (free) to study this.
major effects
- analgesia- relief of pain in absence of impairment of other sensory modalities
- euphoria
- sense of well being, pleasure
- subject to abuse (although vast majority of patients using these drugs chronically for pain do so without abuse or dependance)
opiates vs opioids
- opiates = natural or semi-synthetic
- opioids = synthetic
general effects of opiates
- tend to relax the user
- when injected, user feels imediate "rush"
- sudden surge of pleasure and euphoria; warmth; heaviness in extremities
- other initial and unpleasant effects include restlessness, nausea, and vomiting
- user may repeatidly go back and fourth from feeling alert to drowsy
- with lare doses the use can't be awakened, pupils become smaller. and the skin becomes cold, moist and bluish; breathing slows down and death may occur
endogenous compounts and their precursers
- PDMC ⇒ endorphins
- prepro-enk ⇒ enkephalins
- prepro-dyn ⇒ dynorphins
opiate receptors
- 3 main receptors = Mu, Kappa and Delta
- distributed in CNS and PNS(esp. in areas associated with pain and reward)
- Epsilon (not as well known, won't talk about much)
- Sigma (not officially an opiate receptor, although some opiates do bind)
- many kappa mixed agonists
Mu receptor functions and affinities
- supraspinal and spinal analgesia
- sedation
- inhibition of respiration
- slowed GI transit
- modulation of hormone and neurotransmitter release
- endorphins>enkephalins>dynorphins
Delta receptor functions and affinities
- supraspinal and spinal analgesia
- modulation of hormone and neurotransmitter release
- enkephalins>endorphins and dynorphins
Kappa receptor functions and affinities
- supraspinal and spinal analgesia
- slowed GI transit
- psychotomimetic effects
- dynorphins>endorphins and enkephalins
synaptic location of action for Mu, Delta and Kappa
- presynaptic (primary afferent neuron)
- reduces calcium influx, which causes reduction of transmitter release
- Mu
- Kappa
- postsynaptic (secondary afferent neuron)
- increase potasium conductance which hyperpolarizes cell, reducing excitability(action potential)
- Mu
- Delta
Mu analgesia: spinal and supraspinal
- simultaneous administration of morphine at spinal and supraspinal sites results in synergy with a tenfold decrease in needed total dose of morphine at either site alone
- supraspinal effect of opiates seem to be more responsible for dulling the appreciatation of pain
Mu: respiratory depression
- reduces sensitivity of CO2 sensory receptors in medulla
- problem with OD (tends to correlate to mu activity>kappa activity)
Mu: anti-diarrheal
- are located and act in GI tract
- decrease ACh release
- decrease sensory info from GI tract (food is here!)
- anti-diarrheal drugs that don't cross BBB have been developed
- Diphenoxylate (lomotil)
- Loperamide (imodium)
opiate antagonists
- primarily used to treat overdose of an opiate
- can cause/precipitate severe withdrawal
- prevent or abolish excessive respiratory depression caused by opiates
- also used to block rewarding effects for addicts
- Naloxone
- Naltrexone
Kappa receptor
- produce less respiratory depression as analgesics
- morphine live withdrawal but less severe
- high doses produce dysphoria and hallucinogenic effects
- many drugs are partial agonists and may be antagonist to Mu in some areas leading to less analgesic effects or anti-analgesic effects
- drugs could precipitate withdawal in people using Mu receptor agaonists at the same time...
- Talwin (pentazocine)
- Stadol (butorphanol)
Heroin
- heroin(inactive) crosses BBB(heroin>morphine) where it's deacetylated in the brain to morphine(active)
- no recognized medical uses
Orphanin receptor(NOP receptor)
- most opiates lack affinity, but Naloxone and Lofentanil do bind
- signal transduction nearly identical to opiates (dec. cAMP and inh. N-Ca channels)
- may reduce opiate tolerance
Ultram (tramadol)
- novel analgesic
- weak Mu agonist(naloxone) combined with NE/5HT reuptake inhibitor
- low affinity for Mu receptor but metabolite has much higher affinity
- enantiomer's affinity differ
- R(+) higher affinity for 5HT receptor
- S(-) higher affinity for NE <-- *higher risk of cardiovascular effects
Mu receptor subtypes and functions
- Mu1
- supraspinal analgesia
- euphoria
- physical dependance
- Mu2
- repiratory depresion
- spinal analgesia
- dec. GI motility
Ziconotide
- novel analgesic
- blocker of voltage-gaited N-type calcium channels
- recently approved for intrathecal analgesia in patients with refractory chronic pain
Gapapentin
- novel analgesic
- an anticonvulsant analog of GABA
- is an efective treatment for neuropathic pain
- blocks pain associated with inflammation
- potential site of action includes calcium channels
novel analgesics
- Ziconotide
- Gabapentin
- NMDA antagonists
- THC analogs
- nicotine, serotinin, histamine antagonists
- TRPV-1 receptor antagonists
- responds to temperature related pain
- sensitivity inc. by bradykinin
cough
- antitussive effects of opiates do not correlate with analgesia or respiratory depression
- complex mechanism responding to sensory pathways (mechanical and chemical)
- i.e. obstruction, mucus and edema; tachykinins and bradykinins
dextromethorphan
- cough suppressant in>120 OTC cold medications
- acts centrally on the cough center in the medulla and nucleus tractus solaris to increase cough threshold
- NMDA antagonist
- metabolite (detrorphan) has higher affinity for NMDA receptor
- only at high doses has euphoric effects ⇒ abuse
effects of opiates with high degree of tolerance development
- analgesia
- euphoria, dysphoria
- sedation
- respiratory depression
- antidiuresis
- nausea and vomiting
- cough suppression
effects of opiates with moderate and low degrees of tolerance development
- moderate
- bradycardia
- low
- miosis
- constipation
- convulsions
drugs to treat opiate dependence
- methadone
- suboxone (mu and kappa partial agonist)
- clonidine
About this deck
By: Joshua Pruitt
Textbook:
Pharmacotherapy Handbook, Seventh Edition
Created: 2011-03-28
Size: 26 flashcards
Views: 16
Textbook:
Pharmacotherapy Handbook, Seventh EditionCreated: 2011-03-28
Size: 26 flashcards
Views: 16
About StudyBlue
STUDYBLUE makes things that make you better at school.
Things like online flashcards with photos and audio.
Things like personalized quizzes and friendly reminders about when (and what) to study next.
Think of it as a digital backpack™: access to all of your study materials online and on your phone.
STUDYBLUE exists to make studying efficient and effective for every student, for free. Join us.
“I have been getting MUCH better grades on all my tests for school. Flash cards, notes, and quizzes are great on here. Thanks!”
Kathy
Kathy